Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Shares, No Par Value
Shares outstanding
28,495,649
Total 13F shares
8,633,348
Share change
+3,960,204
Total reported value
$18,127,749
Price per share
$2.10
Number of holders
27
Value change
+$8,211,749
Number of buys
14
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BROADWOOD CAPITAL INC
13F
Company
13%
3,596,680
$16,725,000 31 Dec 2017
13F
VANGUARD GROUP INC
13F
Company
1.3%
356,881
$1,659,000 31 Dec 2017
13F
BlackRock Finance, Inc.
13F
Company
0.73%
207,173
$964,000 31 Dec 2017
13F
Artal Group S.A.
13F
Company
0.53%
150,000
$698,000 31 Dec 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.51%
145,000
$674,000 31 Dec 2017
13F
NORTHERN TRUST CORP
13F
Company
0.15%
44,048
$205,000 31 Dec 2017
13F
Destination Wealth Management
13F
Company
0.1%
29,656
$138,000 31 Dec 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
22,179
$103,000 31 Dec 2017
13F
Bank of New York Mellon Corp
13F
Company
0.06%
16,783
$78,000 31 Dec 2017
13F
MORGAN STANLEY
13F
Company
0.06%
16,041
$75,000 31 Dec 2017
13F
STATE STREET CORP
13F
Company
0.06%
15,899
$73,000 31 Dec 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.06%
15,700
$73,000 31 Dec 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
10,386
$48,000 31 Dec 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
8,465
$39,000 31 Dec 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
7,393
$34,000 31 Dec 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
6,400
$30,000 31 Dec 2017
13F
UBS Group AG
13F
Company
0.02%
5,187
$24,000 31 Dec 2017
13F
STRS OHIO
13F
Company
0.02%
4,600
$21,000 31 Dec 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.01%
4,250
$20,000 31 Dec 2017
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
2,588
$12,000 31 Dec 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
1,946
$9,000 31 Dec 2017
13F
MACQUARIE GROUP LTD
13F
Company
0%
1,400
$7,000 31 Dec 2017
13F
JPMORGAN CHASE & CO
13F
Company
0%
1,050
$5,000 31 Dec 2017
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
746
$3,469 31 Dec 2017
13F
Carroll Financial Associates, Inc.
13F
Company
0%
850
$3,000 31 Dec 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
700
$3,000 31 Dec 2017
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
675
$3,000 31 Dec 2017
13F
BARCLAYS PLC
13F
Company
0%
609
$3,000 31 Dec 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
596
$3,000 31 Dec 2017
13F
Parallax Volatility Advisers, L.P.
13F
Company
0%
546
$3,000 31 Dec 2017
13F
IHT Wealth Management, LLC
13F
Company
0%
563
$2,000 31 Dec 2017
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
500
$2,000 31 Dec 2017
13F
Legal & General Group Plc
13F
Company
0%
384
$2,000 31 Dec 2017
13F
ROYAL BANK OF CANADA
13F
Company
0%
339
$2,000 31 Dec 2017
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
316
$1,000 31 Dec 2017
13F
Advisor Group, Inc.
13F
Company
0%
112
$1,000 31 Dec 2017
13F

Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q1 2018

As of 31 Mar 2018, Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,633,348 shares. The largest 10 holders included BROADWOOD CAPITAL INC, VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., BRIDGEWAY CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, Destination Wealth Management, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
32
Q1 2018 holders
27
Holder diff
-5
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .